Back to REGN
ARS Investment Partners, LLC → REGN
ARS Investment Partners, LLC REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$33.8M
Q3 2026
Peak value
$35M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $27.4M |
| Q1 2026 | $35M |
| Q2 2026 | $28.4M |
| Q3 2026 | $33.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $33.8M | 44.5K | — | — |
| Q2 2026 | $28.4M | 45.5K | — | — |
| Q1 2026 | $35M | 45.3K | — | — |
| Q4 2025 | $27.4M | 35.4K | — | — |